The rate of estrogen receptor‐conversion associated with tumor progression in estrogen receptor‐positive breast cancer patients following adjuvant Tamoxifen administration

BACKGROUND: Hormone Receptor (HR)‐discordance between primary breast cancer and metastasis is a known biological phenomenon. Discordance studies usually comprise a heterogeneous group of HR‐positive and negative patients and allow for the comparison of changes in HR‐status from the primary to the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Djahansouzi, Sirus, Hanstein, Bettina, Rein, Daniel, Clees, Michel, Rath, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789621/
https://www.ncbi.nlm.nih.gov/pubmed/34086424
http://dx.doi.org/10.1002/cnr2.1431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789621/
https://www.ncbi.nlm.nih.gov/pubmed/34086424
http://dx.doi.org/10.1002/cnr2.1431

Ejemplares similares